|
Dec 1
|
Jaypirca® (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor
|
|
Dec 1
|
UPDATE 1-US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
|
|
Dec 1
|
Annovis Bio (ANVS) Stock Surges 38% in a Month: Here's Why
|
|
Dec 1
|
Weight-Loss Stocks Are Getting Pricey. Time to Worry About a Bubble?
|
|
Dec 1
|
1 Underrated Reason to Buy Eli Lilly Stock
|
|
Dec 1
|
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Dec 1
|
Pfizer drops plan for twice-daily obesity pill due to side effects
|
|
Dec 1
|
December Looks Great For Investors Who Own 9 Stocks
|
|
Dec 1
|
UPDATE 4-Pfizer drops twice-daily version of obesity pill over side effects
|
|
Dec 1
|
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
|
|
Dec 1
|
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
|
|
Nov 30
|
Weight loss drugs likely to boost apparel stocks: Survey
|
|
Nov 30
|
The Zacks Analyst Blog Highlights AbbVie, J&J, Eli Lilly, Pfizer
|
|
Nov 30
|
Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?
|
|
Nov 29
|
20 Most Fit Countries in the World
|
|
Nov 29
|
12 Best Quality Stocks To Buy Now
|
|
Nov 13
|
12 Best Low Beta Stocks To Buy
|
|
Nov 13
|
PRIMECAP Management Adjusts Portfolio, Notably Trims Eli Lilly Stake
|
|
Nov 13
|
Novo Nordisk Stock Skids — But These Weight-Loss Results Are 'Hard To Ignore'
|
|
Nov 13
|
Cost Is the Focus as Novo Nordisk Data Make Broader Case for Weight-Loss Drugs
|